Summary
The product SUSTANON 250, manufactured by Unique Pharma, underwent independent testing to confirm its authenticity and potency. The sample, identified by batch number GH65732K, was submitted by the reseller Opitropin.EU and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis measured the total concentration of testosterone esters at 240.29 mg/ml, slightly below the labeled claim of 250 mg/ml by 3.88%.
The testing process began on 01 August 2022, with the sample received on 09 August 2022, and analysis completed on 12 August 2022. While the results confirm relatively accurate dosing, it’s important to critically evaluate reseller-submitted samples to ensure reliability. Resellers may selectively submit high-quality batches, raising questions about product consistency across the market. Independent third-party testing remains vital for comprehensive validation. This report is intended as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: Unique Pharma
- Product Name: SUSTANON 250
- Active Ingredient: Testosterone blend
- Batch Number: GH65732K
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #22631
- Testing Ordered: 01 August 2022
- Sample Received: 09 August 2022
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Opitropin.EU (Reseller)
- Analysis Paid For By: Opitropin.EU
Testing Results
- Specification: 250 mg/ml (as stated on the label)
- Measured Concentration: 240.29 mg/ml
- Accuracy: 96.12% (-3.88% below label claim)
- Variance: -3.88 mg/ml
Detailed Breakdown
- Testosterone Propionate (TP): 27.57 mg/ml
- Testosterone Phenylpropionate (TPP): 57.06 mg/ml
- Testosterone Isocaproate (TI): 55.54 mg/ml
- Testosterone Decanoate (TD): 100.13 mg/ml
Verification Details
- Verification URL: https://janoshik.com/tests/22631_APGNLCUIFQS4
Evaluation of Reseller-Submitted Testing
This analysis confirms the relative accuracy of the tested product but warrants scrutiny due to its submission and funding by the reseller Opitropin.EU. Resellers may selectively choose optimal batches for testing, which might not reflect overall market consistency. While Janoshik Analytical is recognized for its transparency and rigorous protocols, additional third-party testing across multiple batches would help validate the findings comprehensively.
Conclusion
The analysis indicates that SUSTANON 250 by Unique Pharma is slightly underdosed, with a measured concentration of 240.29 mg/ml, reflecting relatively strong quality control for this batch. However, further testing across different batches is crucial for consistent assurance. This report aims to support educational and harm reduction efforts, assisting consumers in making informed choices regarding anabolic steroid products.
Disclaimer
This report is published for educational and harm reduction purposes. Reseller-submitted testing may introduce biases; however, it still provides valuable insights when critically evaluated alongside independent third-party results. Readers are encouraged to use this information responsibly.
